ABSI

Absci Corp

9.07

Oct 20 • 3:59 PM ET +0.53 (6.21%)

9.19

Aftermarket • 7:30 PM ET +0.12 (1.28%)

Healthcare Biotechnology USA Small NASD

Peers: GENB ABCL RXRX SDGR XNCR TWST DNA MANE CERT EVAX

| Held by: ARKG VTI XBI IWM VXF IWO IBB VTWO SCHA FYC

Scroll to Statements

Index	RUT
Market Cap	1.56B
Enterprise Value	1.36B
Income	-121.08M
Sales	1.56M
Book/sh	1.43
Cash/sh	1.17
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	140
IPO	Jul 22, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	997.78
P/B	6.32
P/C	7.74
P/FCF	-
EV/EBITDA	-
EV/Sales	871.30
Quick Ratio	10.63
Current Ratio	10.63
Debt/Eq	0.02
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-0.80
EPS next Y	-0.72
EPS next Q	-0.19
EPS this Y	4.95%
EPS next Y	9.42%
EPS next 5Y	11.87%
EPS past 3/5Y	9.99% -9.45%
Sales past 3/5Y	-21.31% -10.14%
EPS Y/Y TTM	15.36%
Sales Y/Y TTM	-62.28%
EPS Q/Q	11.98%
Sales Q/Q	-46.37%
Earnings	Nov 12 BMO
EPS/Sales Surpr.	-9.95% -67.38%

Insider Own	13.70%
Insider Trans	0.21%
Inst Own	83.64%
Inst Trans	19.46%
ROA	-50.57%
ROE	-57.72%
ROIC	-48.87%
Gross Margin	-610.70%
Oper. Margin	-8411.27%
Profit Margin	-7756.37%
SMA20	-6.70%
SMA50	-2.79%
SMA200	45.98%
Trades

Shs Outstand	171.56M
Shs Float	148.10M
Short Float	25.28%
Short Ratio	11.13
Short Interest	37.44M
52W High	12.06 -24.76%
52W Low	2.24 304.91%
Volatility	7.75% 9.14%
ATR (14)	0.81
RSI (14)	47.76
Beta	2.24
Rel Volume	0.84
Avg Volume	3.36M
Volume	2,825,766

Perf Week	-0.33%
Perf Month	-7.64%
Perf Quarter	10.07%
Perf Half Y	132.56%
Perf YTD	159.89%
Perf Year	88.76%
Perf 3Y	619.84%
Perf 5Y	-18.95%
Perf 10Y	-
Recom	1.18
Target Price	14.90
Prev Close	8.54
Price	9.07
Change %	6.21%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-04-26	Initiated	Leerink Partners	Outperform	$12
May-28-26	Initiated	BTIG Research	Buy	$9
Jan-08-26	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$4.32
Oct-02-25	Initiated	JP Morgan	Overweight
Jul-03-25	Resumed	Morgan Stanley	Overweight	$7
Jan-22-25	Initiated	Needham	Buy	$9
Oct-02-24	Initiated	Guggenheim	Buy	$10
Jul-03-24	Initiated	Morgan Stanley	Overweight	$7
Mar-14-24	Initiated	Scotiabank	Sector Outperform	$13
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$3
May-04-23	Initiated	H.C. Wainwright	Buy	$4
Aug-12-22	Downgrade	JP Morgan	Overweight → Underweight
Jul-18-22	Initiated	Truist	Buy	$8
Mar-02-22	Resumed	Cowen	Market Perform
Feb-01-22	Initiated	Berenberg	Buy	$28
Nov-10-21	Downgrade	BofA Securities	Neutral → Underperform	$10
Oct-15-21	Resumed	Cowen	Market Perform
Aug-16-21	Initiated	Stifel	Hold	$28
Aug-16-21	Initiated	Credit Suisse	Outperform	$40
Aug-16-21	Initiated	Cowen	Market Perform

Show Previous Ratings

Oct-13-26 08:00AM	Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026 (GlobeNewswire) -5.89%
Sep-24-26 08:00AM	Absci Announces Preliminary Details for Phase 2 STORYLINE Trial of AI-Designed Antibody ABS-201 for Endometriosis (GlobeNewswire) +6.16%
Sep-03-26 08:55AM	AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 (PR Newswire)
Sep-01-26 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-30-26 11:21PM	Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade (BeInCrypto)
08:22PM	Loading…
Aug-11-26 08:22PM	Absci Corporation Q2 2026 Earnings Call Summary (Moby)
04:05PM	Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results (GlobeNewswire)
Aug-10-26 09:17AM	Earnings To Watch: Absci Corp (ABSI) Q2 2026 -- GF Value Sees 92% Downside (GuruFocus.com)
Jul-24-26 09:10AM	A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed (PR Newswire) -6.32%
Jul-15-26 08:45AM	As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 (PR Newswire)
Jul-14-26 04:05PM	Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 (GlobeNewswire)
Jul-06-26 08:55AM	As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models (PR Newswire)
08:45AM	The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel (PR Newswire)
Jun-26-26 02:39PM	Healthcare stocks have become a haven for investors ditching tech (MarketWatch) +6.66%
06:27AM	Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy (Pharmaceutical Technology)
11:24PM	Loading…
Jun-24-26 11:24PM	Why Did UAL, GLW, ABSI Stocks Surge To 52-Week Highs Today? (Stocktwits) +35.96%
03:55PM	ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise (Stocktwits)
08:59AM	Absci Shares Soar After Positive Early Clinical Results for Hair Loss Therapy (ABSI) (InvestorsHub)
08:07AM	Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble (Investing.com)
06:35AM	Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors (GlobeNewswire)
06:30AM	Absci Announces Positive Interim Phase 1 Data from the HEADLINE Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) (GlobeNewswire)
Jun-16-26 08:45AM	The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It (PR Newswire)
Jun-12-26 09:00AM	MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery (Business Wire)
May-20-26 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.91%
May-13-26 11:11AM	Marvell Stock Climbs After AMD Reveals Surprise Stake (GuruFocus.com)
May-07-26 04:05PM	Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results (GlobeNewswire)
May-06-26 09:28AM	Absci Corp (ABSI) Q1 2026 Earnings Report Preview: What To Look For (GuruFocus.com) +6.06%
May-04-26 08:11PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.23%
Apr-23-26 04:05PM	Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 (GlobeNewswire) +7.88%
Apr-08-26 08:00AM	Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
08:30AM	Loading…
Mar-25-26 08:30AM	Absci Corporation Q4 2025 Earnings Call Summary (Moby)
Mar-24-26 11:01PM	Absci Corp (ABSI) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience (GuruFocus.com)
04:05PM	Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results (GlobeNewswire)
08:00AM	Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic (GlobeNewswire)
Mar-23-26 09:17AM	Earnings To Watch: Absci Corp (ABSI) Reports Q4 2025 Result (GuruFocus.com)
Mar-06-26 04:05PM	Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -8.11% +5.46%
Mar-03-26 08:00AM	Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer (GlobeNewswire) -8.21%
Mar-02-26 12:15PM	Absci Conference: Agentic AI Push and ABS-201 Hair-Loss Program Take Center Stage (MarketBeat)
Feb-24-26 08:00AM	Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 (GlobeNewswire)
Feb-17-26 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-14-26 09:07PM	Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch (MarketBeat) -8.96%
02:13PM	Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials (Insider Monkey)
Dec-31-25 11:13AM	Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment (Insider Monkey)
Dec-30-25 12:18PM	Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial (Insider Monkey)
Dec-27-25 07:43AM	Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential (Insider Monkey)
Dec-18-25 01:14AM	Absci Corporation (NASDAQ:ABSI)'s ABS-201 Shows Promise in Hair Loss Treatment, Analysts See Upside (Insider Monkey)
Dec-16-25 08:00AM	Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-12-25 10:15AM	AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave (PR Newswire) -5.21%
Dec-11-25 08:00AM	Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201 Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization (GlobeNewswire)
Dec-10-25 08:00AM	Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research (GlobeNewswire) +12.78%
Dec-05-25 10:37AM	ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study (Zacks)
Dec-04-25 08:00AM	Absci Announces First Participants Dosed in Phase 1/2a HEADLINE Trial of AI-Designed Antibody ABS-201 for Androgenetic Alopecia (GlobeNewswire) +13.37%
06:05AM	10 AI Stocks Worth Buying Right Now (Motley Fool)
Nov-13-25 12:02AM	Absci Corp (ABSI) Q3 2025 Earnings Call Highlights: Strategic Shifts and Strong Cash Position ... (GuruFocus.com) -22.35%
Nov-12-25 05:25PM	Absci Corporation (ABSI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results (GlobeNewswire)
Nov-11-25 07:28AM	Absci Corp (ABSI) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-10-25 08:15AM	uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-06-25 09:15AM	Invivyd, Inc. (IVVD) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -5.77%
Oct-29-25 04:05PM	Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 (GlobeNewswire) -6.41%
Oct-27-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.39%
Oct-15-25 08:00AM	Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial (GlobeNewswire) +28.21%
Oct-13-25 12:12PM	2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk (MarketBeat)
Sep-21-25 09:26AM	Absci Corporation (ABSI) Secures $64M Financing to Drive AI Drug Discovery Through 2028 (Insider Monkey)
Sep-11-25 08:00AM	Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD (GlobeNewswire) +15.13%
Aug-25-25 04:05PM	Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg (GlobeNewswire)
Aug-20-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-13-25 03:12AM	Absci Corp (ABSI) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges (GuruFocus.com) +5.05%
Aug-12-25 05:20PM	Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results (GlobeNewswire)
Aug-11-25 09:31AM	Absci Corp (ABSI) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Aug-07-25 10:00AM	SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
02:00AM	Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target (GlobeNewswire)
Aug-06-25 10:00AM	Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Aug-05-25 05:15PM	Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-04-25 05:15PM	Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-30-25 04:05PM	Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 (GlobeNewswire)
Jul-25-25 09:56AM	Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? (Zacks) -17.66%
Jul-24-25 08:45PM	Absci Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:54PM	Absci Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jul-11-25 07:15PM	Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target (Insider Monkey)
Jul-07-25 08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire) -6.86%
08:00AM	Absci Appoints Biopharma Leader Mary Szela to Board of Directors (GlobeNewswire)
May-20-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-14-25 08:32AM	Q1 2025 Absci Corp Earnings Call (Thomson Reuters StreetEvents)
03:17AM	Absci Corp (ABSI) Q1 2025 Earnings Call Highlights: Transition to Clinical Stage and Strong ... (GuruFocus.com)
May-13-25 05:30PM	Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results (GlobeNewswire)
04:01PM	Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease (GlobeNewswire)
May-12-25 09:35AM	What To Expect From Absci Corp (ABSI) Q1 2025 Earnings (GuruFocus.com) +6.55%
Apr-14-25 04:05PM	Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025 (GlobeNewswire)
11:40AM	Absci: FDA Announcement Provides Only A Modest Tailwind (Seeking Alpha)
Apr-03-25 03:15PM	Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market (Seeking Alpha) -9.88%
Mar-31-25 07:15AM	Which Healthcare Stock Is the Best Buy Right Now? (MarketBeat) -7.04%
Mar-26-25 08:00AM	Absci to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.54%
Mar-21-25 10:57PM	Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Mar-19-25 09:08AM	Q4 2024 Absci Corp Earnings Call (Thomson Reuters StreetEvents)
03:03AM	Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... (GuruFocus.com)
Mar-18-25 04:05PM	Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-04-25 04:05PM	Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Szela Mary T	Director	Jun 30 '26	Buy	11.54	12,900	148,866	21,300	Jul 06 04:06 PM
Pangalos Menelas N	Director	May 13 '26	Buy	5.36	37,453	200,748	232,308	May 13 04:05 PM
Busch Andreas	Chief Innovation Officer	Mar 12 '26	Buy	2.29	100,000	229,000	421,446	Mar 16 04:17 PM
Pangalos Menelas N	Director	Feb 27 '26	Buy	2.74	75,095	205,760	189,055	Mar 03 04:13 PM
McClain Sean	Chief Executive Officer	Feb 23 '26	Option Exercise	1.21	396,399	479,643	8,730,966	Feb 25 06:05 PM
McClain Sean	Chief Executive Officer	Feb 02 '26	Sale	2.99	26,761	80,015	8,334,567	Feb 04 04:52 PM
Jonasson Zachariah	CFO / CBO	Feb 02 '26	Sale	2.99	17,496	52,313	383,538	Feb 04 04:51 PM
VAN HOUTEN FRANS	Director	Dec 05 '25	Buy	3.72	40,000	148,800	63,320	Dec 09 04:04 PM

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

FounderMr. Sean McClain

Chief Business Officer & CFODr. Zachariah Jonasson Ph.D.

Senior VP & Chief Accounting OfficerMr. Todd Bedrick CPA

CVP of Finance & Head of Investor RelationsMr. Alexander Khan CPA

Chief Legal OfficerMs. Shelby Walker J.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABSI

Absci Corp

Upgrade your Finviz experience